Impact of a New Nasal Pillows Mask on Patients’ Acceptance, Compliance, and Willingness to Remain on CPAP Therapy

Abstract

Aim. Continuous positive airway pressure (CPAP) masks are a key factor in patient compliance. This program assessed the performance of a new nasal pillows mask (NPM) on a variety of new and established obstructive sleep apnea (OSA) patients using CPAP therapy. Methods. Five programs were developed to assess the new NPM [AirFit P10, ResMed] on naïve patients; patients established on another NPM; patients using a nasal mask; patients with low CPAP compliance; and patients who wished to stop using CPAP therapy. Results. A total of 212 patients were included. In naïve patients, CPAP usage after 3 months was 5.9 ± 1.7 hours/night, compared with the control group at 4.6 ± 2.4 hours/night (p < 0.05). In patients established on another NPM, usage improved to 7.4 ± 1.1 hours/night versus 6.7 ± 1.4 (p = 0.001). 78% of nasal mask users wished to continue using the new NPM. Low compliance patients improved with an average of 0.87 hours/night (p = 0.001) when using the new NPM. In patients at the point of quitting CPAP, 60% continued with therapy using the new NPM. Conclusion. The new NPM mask performed well in a variety of clinical groups of OSA patients receiving CPAP therapy and shows that technical advances in CPAP masks can improve patient compliance.

Adaptive servo-ventilation in patients with chronic heart failure and sleep disordered breathing: predictors of usage

“…Also, some physiological parameters such as lung function and blood gas measures were not systematically assessed. Some known predictors for positive airway pressure intolerance such as high nasal resistance [17,18], uncomfortable mask [19][20][21], financial aspects, loss of intimacy with the bed partner [22], and claustrophobia [22,23] were not systematically assessed. As this is an observational study, causal effects cannot be proven, and selection bias can occur.…”

“…Previous studies support that longer usage of PAP therapy leads to better therapy success [13][14][15]. For example, longer CPAP usage is associated with improved blood pressure control [15][16][17] as well as cognitive functions [17,18]. In most ASV and CPAP studies, sufficient therapy usage is considered to be a usage above 4 h per night [16,[18][19][20][21][22][23].…”

“…For example, longer CPAP usage is associated with improved blood pressure control [15][16][17] as well as cognitive functions [17,18]. In most ASV and CPAP studies, sufficient therapy usage is considered to be a usage above 4 h per night [16,[18][19][20][21][22][23]. The usage of ASV therapy in the previous studies ranged between 3.7 and 5.2 h/night [9][10][11][24][25][26].…”

Einfluss einer strukturierten Nachsorge auf die Therapietreue bei OSAS-Patienten unter CPAP-Therapie

“…Somit rückte das Thema der Nachsorge in den Blickpunkt. In der Vergangenheit existieren bereits Studien, die zeigen, dass sich eine Nachsorge positiv auf die Therapietreue auswirkt [22,23,24,25,26,27]. Dieser positive Effekt zeigte sich für verschiedene Konzepte der Nachsorge, so z.…”

“…sind Interventionen innerhalb der Nachsorge häufig gut zugänglich und scheinen die Therapietreue zu beeinflussen [10,11,12]. Es zeigte sich beispielsweise, dass Patienten, bei denen aufgrund schlechter Maskenakzeptanz ein Maskenwechsel notwendig war, ein deutlich höheres Risiko für ein Therapieversagen hatten [10], dass aber ein Maskenwechsel bei bestehender Indikation dennoch die Therapieabbruchrate verringern kann [27]. CPAP-versorgte OSAS-Patienten scheinen eine erhöhte Prävalenz für klaustrophobische Tendenzen zu haben, welche die kurz- und langzei-tige Therapietreue verschlechtern [12] und ggf.…”